Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein

FEBS Lett. 1996 Apr 8;384(1):25-30. doi: 10.1016/0014-5793(96)00271-2.

Abstract

A monoclonal antibody (AP422) specific for phosphoserine 422 in microtubule-associated protein tau has been produced. It strongly labels paired helical filament (PHF) tau from Alzheimer's disease brain in a phosphorylation-dependent manner. By contrast, AP422 only labels a small fraction of fetal tau and a very small fraction of tau from adult brain. The amount of tau phosphorylated at Ser-422 in normal brain is minor relative to that phosphorylated at sites recognized by other phosphorylation-dependent anti-tau antibodies of known epitope. It follows that AP422 is the most specific anti-tau antibody available for detecting the neurofibrillary lesions of Alzheimer's disease. We also show that Ser-422 in tau is a good in vitro substrate for mitogen-activated protein kinase, but not for glycogen synthase kinase-3 or neuronal cdc2-like kinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism
  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal*
  • Antibody Specificity
  • Brain / metabolism*
  • Cerebral Cortex / cytology
  • Cerebral Cortex / metabolism
  • Electrophoresis, Polyacrylamide Gel
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Microscopy, Immunoelectron
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Phosphopeptides / chemical synthesis
  • Phosphopeptides / chemistry
  • Phosphopeptides / immunology*
  • Phosphorylation
  • Phosphoserine
  • Rats
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / immunology
  • Recombinant Proteins / metabolism
  • tau Proteins / analysis
  • tau Proteins / immunology*
  • tau Proteins / metabolism*

Substances

  • Antibodies, Monoclonal
  • Phosphopeptides
  • Recombinant Proteins
  • tau Proteins
  • Phosphoserine